Please login to the form below

Not currently logged in
Email:
Password:

Roche's HIV-1 test approved in Europe

Roche has announced that it has received CE Mark certification for its dual-target HIV-1 test

Roche has announced that it has received CE Mark certification for its dual-target HIV-1 test.

This certification allows the product, which amplifies and detects two separate regions of the HIV-1 genome simultaneously, to be sold for clinical use in the European Union. According to the company, this provides reliable test results even when mutations are present.

"HIV mutations are a serious problem. Because it is impossible to predict when these mutations will occur, we have designed this test to detect all HIV-1 (Group M and O) strains," said Daniel O'Day, president and CEO of Roche Molecular Diagnostics. "This innovative fully-automated solution will provide reliable results for laboratories and physicians to more confidently and efficiently treat HIV-1 patients undergoing therapy."

HIV is a retrovirus that infects cells of the human immune system. In the early stages of infection, the person experiences no symptoms. Untreated, HIV will usually develop into AIDS within 10 to 15 years.

Roche's test is highly sensitive and can detect both very low and very high levels of the virus, a key indicator of the need for more or less aggressive treatment.
 

16th December 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics